Literature DB >> 9889231

Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.

M J McCullough1, K V Clemons, D A Stevens.   

Abstract

There have been increased reports of the isolation of unusual genotypic groups of Candida albicans (groups C and D) based on a well-defined genotypic method; this method uses cellular DNA digested with the EcoRI enzyme and the restriction fragment length polymorphisms (RFLPs) generated by agarose gel electrophoresis. The aim of the present study was to use additional molecular tools to characterize these unusual strains and to compare them with authentic strains of C. dubliniensis, a recently delineated species, and type I C. stellatoidea. The RFLPs of PCR products generated from the intergenic transcribed spacer (ITS) region did not differentiate among C. albicans genotypes A, B, and C and type I C. stellatoidea. However, this method did differentiate the C. albicans genotype D strains, which were identical to C. dubliniensis. The RFLPs generated by HaeIII digestion of the PCR products of the V3 region of the 25S rRNA gene (rDNA) could differentiate the same groups as RFLP analysis of the PCR amplicon of the ITS region. C. albicans genotype B isolates have been shown to have a transposable intron in the 25S rDNA, whereas genotype A isolates do not; C. dubliniensis strains also have an intron that is larger than that in genotype B C. albicans strains but that is in the same location. PCR designed to span this region resulted in a single product for C. albicans genotype A (450 bp), B (840 bp), type 1 C. stellatoidea (840 bp), and C. dubliniensis (1,080 bp), whereas the C. albicans genotype C isolates had two major products (450 and 840 bp). All C. albicans genotype D isolates gave a PCR product identical to that given by C. dubliniensis. These results indicate that those strains previously designated C. albicans genotype D are in fact C. dubliniensis, that no differences were found between type 1 C. stellatoidea and C. albicans genotype B strains, and that the C. albicans genotype C strains appear to have the transposable intron incompletely inserted throughout the ribosomal repeats in their genomes. The results of the antifungal susceptibility testing of 105 of these strains showed that, for fluconazole, strains of C. dubliniensis were significantly more susceptible than strains of each of the C. albicans genotypes (genotypes A, B, and C). The flucytosine susceptibility results indicated that strains of C. albicans genotype A were significantly less susceptible than either C. albicans genotype B or C. albicans genotype C strains. These results indicate that there is a correlation between the Candida groups and antifungal susceptibility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889231      PMCID: PMC84325     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

Review 1.  Epidemiology of fungal infections: the promise of molecular typing.

Authors:  M A Pfaller
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

2.  Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors:  S Scherer; D A Stevens
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

3.  Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype.

Authors:  B L Wickes; J E Golin; K J Kwon-Chung
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

4.  Epidemiologic study by DNA typing of a Candida albicans outbreak in heroin addicts.

Authors:  K V Clemons; G S Shankland; M D Richardson; D A Stevens
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

5.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

6.  Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species.

Authors:  B B Magee; T M D'Souza; P T Magee
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

7.  Association of electrophoretic karyotype of Candida stellatoidea with virulence for mice.

Authors:  K J Kwon-Chung; B L Wickes; W G Merz
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

8.  Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype.

Authors:  D A Stevens; F C Odds; S Scherer
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

9.  Evidence that Candida stellatoidea type II is a mutant of Candida albicans that does not express sucrose-inhibitable alpha-glucosidase.

Authors:  K J Kwon-Chung; J B Hicks; P N Lipke
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

10.  Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA.

Authors:  D W Williams; M J Wilson; M A Lewis; A J Potts
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more
  56 in total

1.  Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K Lafe; U Bui; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Molecular epidemiology of Candida.

Authors:  David A Stevens
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan.

Authors:  Kuo-Wei Chen; Yee-Chun Chen; Hsiu-Jung Lo; Frank C Odds; Tzu-Hui Wang; Chi-Yang Lin; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Rapid identification of candida species by TaqMan PCR.

Authors:  M Guiver; K Levi; B A Oppenheim
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

5.  Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.

Authors:  C P Girish Kumar; Ahmed Medhat Hanafy; Masakazu Katsu; Yuzuru Mikami; Thangam Menon
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

6.  Molecular phylogenetics of Candida albicans.

Authors:  Frank C Odds; Marie-Elisabeth Bougnoux; Duncan J Shaw; Judith M Bain; Amanda D Davidson; Dorothée Diogo; Mette D Jacobsen; Maud Lecomte; Shu-Ying Li; Arianna Tavanti; Martin C J Maiden; Neil A R Gow; Christophe d'Enfert
Journal:  Eukaryot Cell       Date:  2007-04-06

7.  Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area.

Authors:  Michael J McCullough; Jacks J Jorge; Flavio Lejbkowicz; Eli Lefler; Faris Nassar; Karl V Clemons; David A Stevens
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

8.  Molecular analysis of Candida albicans isolates from clinical specimens.

Authors:  Melahat Gurbuz; Ilknur Kaleli
Journal:  Mycopathologia       Date:  2009-12-10       Impact factor: 2.574

9.  Species distribution and virulence factors of Candida spp. isolated from the oral cavity of kidney transplant recipients in Brazil.

Authors:  Guilherme Maranhão Chaves; Mariana Guimarães Diniz; Walicyranison Plinio da Silva-Rocha; Luanda Bárbara Ferreira Canário de Souza; Libia Augusta Maciel Gondim; Maria Angela Fernandes Ferreira; Terezinha Inez Estivalet Svidzinski; Eveline Pipolo Milan
Journal:  Mycopathologia       Date:  2013-03-29       Impact factor: 2.574

10.  Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Authors:  Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.